179 related articles for article (PubMed ID: 29898631)
1. Development of a Phototoxicity Testing Strategy for Accurate Photosafety Evaluation of Pharmaceuticals Based on the Assessment of Possible Melanin-Binding Effects.
Reinen J; van Sas P; van Huygevoort T; Rubio L; Scase K; Wenker M
Int J Toxicol; 2018; 37(4):296-307. PubMed ID: 29898631
[TBL] [Abstract][Full Text] [Related]
2. Integrated preclinical photosafety testing strategy for systemically applied pharmaceuticals.
Schümann J; Boudon S; Ulrich P; Loll N; Garcia D; Schaffner R; Streich J; Kittel B; Bauer D
Toxicol Sci; 2014 May; 139(1):245-56. PubMed ID: 24519524
[TBL] [Abstract][Full Text] [Related]
3. Assessment of phototoxicity in pigmented Long-Evans rat: sparfloxacin and 8-methoxypsoralen.
Turnock S; Gerbeix C; Thirion-Delalande C; Pearson N; Forster R
Regul Toxicol Pharmacol; 2018 Feb; 92():303-314. PubMed ID: 29196029
[TBL] [Abstract][Full Text] [Related]
4. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry.
Lynch AM; Wilcox P
Exp Toxicol Pathol; 2011 Mar; 63(3):209-14. PubMed ID: 20060695
[TBL] [Abstract][Full Text] [Related]
5. A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10.
Bauer D; Buckley LA; Delafoy L; Ellinger-Ziegelbauer H; Fellows MD; Gerets HHJ; Howe J; Kaijser G; Nicolette J; Pettersen BA; Schimpf B
Regul Toxicol Pharmacol; 2021 Oct; 125():105017. PubMed ID: 34311056
[TBL] [Abstract][Full Text] [Related]
6. A new photosafety screening strategy based on in chemico photoreactivity and in vitro skin exposure for dermally-applied chemicals.
Iyama Y; Sato H; Seto Y; Onoue S
Toxicol Lett; 2019 Dec; 317():45-52. PubMed ID: 31557510
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and International Harmonization of Photosafety Testing Strategy].
Onoue S
Yakugaku Zasshi; 2021; 141(6):807-812. PubMed ID: 34078785
[TBL] [Abstract][Full Text] [Related]
8. Photochemical and Pharmacokinetic Characterization of Orally Administered Chemicals to Evaluate Phototoxic Risk.
Iyama Y; Sato H; Seto Y; Onoue S
J Pharm Sci; 2019 Mar; 108(3):1303-1308. PubMed ID: 30336153
[TBL] [Abstract][Full Text] [Related]
9. Photosafety screening of phenothiazine derivatives with combined use of photochemical and cassette-dosing pharmacokinetic data.
Onoue S; Kato M; Inoue R; Seto Y; Yamada S
Toxicol Sci; 2014 Feb; 137(2):469-77. PubMed ID: 24241722
[TBL] [Abstract][Full Text] [Related]
10. The abdominal skin of female Sprague-Dawley rats is more sensitive than the back skin to drug-induced phototoxicity.
Kuga K; Yasuno H; Sakai Y; Harada Y; Shimizu F; Miyamoto Y; Takamatsu Y; Miyamoto M; Sato K
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):46-55. PubMed ID: 28688881
[TBL] [Abstract][Full Text] [Related]
11. Assessment of 8-methosypsoralen, lomefloxacin, sparfloxacin, and Pirfenidone phototoxicity in Long-Evans rats.
Adachi T; Satou Y; Satou H; Shibata H; Miwa S; Iwase Y; Yamamoto T; Nishida A; Masutomi N
Int J Toxicol; 2015; 34(1):16-23. PubMed ID: 25432946
[TBL] [Abstract][Full Text] [Related]
12. Non-animal photosafety assessment approaches for cosmetics based on the photochemical and photobiochemical properties.
Onoue S; Suzuki G; Kato M; Hirota M; Nishida H; Kitagaki M; Kouzuki H; Yamada S
Toxicol In Vitro; 2013 Dec; 27(8):2316-24. PubMed ID: 24134854
[TBL] [Abstract][Full Text] [Related]
13. Exploratory and regulatory assessments on photosafety of new drug entities.
Seto Y; Hosoi K; Takagi H; Nakamura K; Kojima H; Yamada S; Onoue S
Curr Drug Saf; 2012 Apr; 7(2):140-8. PubMed ID: 22873498
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Phototoxicity: Clinical Observations versus Histopathological Findings.
Learn DB; Elliott MW
Toxicol Pathol; 2016 Jun; 44(4):545-51. PubMed ID: 27073086
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of chemical photoreactivity and the relationship to phototoxicity.
Kleinman MH; Smith MD; Kurali E; Kleinpeter S; Jiang K; Zhang Y; Kennedy-Gabb SA; Lynch AM; Geddes CD
Regul Toxicol Pharmacol; 2010 Nov; 58(2):224-32. PubMed ID: 20600453
[TBL] [Abstract][Full Text] [Related]
16. Strategic photosafety screening system consisting of in chemico photoreactivity and in vitro skin exposure for quinolone derivatives.
Iyama Y; Sato H; Seto Y; Onoue S
Eur J Pharm Sci; 2020 Apr; 146():105257. PubMed ID: 32035110
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of skin phototoxicity with three drugs by an in vivo mouse model.
Matsumoto N; Akimoto A; Kawashima H; Kim S
J Toxicol Sci; 2010 Feb; 35(1):97-100. PubMed ID: 20118629
[TBL] [Abstract][Full Text] [Related]
18. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
19. [Current Issues in Photosafety Evaluation].
Onoue S; Kouzuki H; Toyoda A; Fueki O; Hosoi K; Kojima H; Ashikaga T; Onodera H
Yakugaku Zasshi; 2021; 141(1):111-124. PubMed ID: 33390438
[TBL] [Abstract][Full Text] [Related]
20. Non-animal photosafety screening for complex cosmetic ingredients with photochemical and photobiochemical assessment tools.
Nishida H; Hirota M; Seto Y; Suzuki G; Kato M; Kitagaki M; Sugiyama M; Kouzuki H; Onoue S
Regul Toxicol Pharmacol; 2015 Aug; 72(3):578-85. PubMed ID: 26048216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
